These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31417557)

  • 1. Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis.
    Ciolac D; Luessi F; Gonzalez-Escamilla G; Koirala N; Riedel C; Fleischer V; Bittner S; Krämer J; Meuth SG; Muthuraman M; Groppa S
    Front Immunol; 2019; 10():1779. PubMed ID: 31417557
    [No Abstract]   [Full Text] [Related]  

  • 2. Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis.
    Marastoni D; Crescenzo F; Pisani AI; Zuco C; Schiavi G; Benedetti G; Ricciardi GK; Montemezzi S; Pizzini FB; Tamanti A; Calabrese M
    Mult Scler; 2022 Nov; 28(13):2090-2098. PubMed ID: 35765211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
    Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
    Fleischer V; Friedrich M; Rezk A; Bühler U; Witsch E; Uphaus T; Bittner S; Groppa S; Tackenberg B; Bar-Or A; Zipp F; Luessi F
    Mult Scler; 2018 Apr; 24(5):632-641. PubMed ID: 28436295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.
    Preziosa P; Pagani E; Mesaros S; Riccitelli GC; Dackovic J; Drulovic J; Filippi M; Rocca MA
    Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gray matter integrity predicts white matter network reorganization in multiple sclerosis.
    Radetz A; Koirala N; Krämer J; Johnen A; Fleischer V; Gonzalez-Escamilla G; Cerina M; Muthuraman M; Meuth SG; Groppa S
    Hum Brain Mapp; 2020 Mar; 41(4):917-927. PubMed ID: 32026599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.
    Sotirchos ES; Gonzalez-Caldito N; Dewey BE; Fitzgerald KC; Glaister J; Filippatou A; Ogbuokiri E; Feldman S; Kwakyi O; Risher H; Crainiceanu C; Pham DL; Van Zijl PC; Mowry EM; Reich DS; Prince JL; Calabresi PA; Saidha S
    Mult Scler; 2020 Mar; 26(3):312-321. PubMed ID: 30741108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis.
    Parisi L; Rocca MA; Mattioli F; Riccitelli GC; Capra R; Stampatori C; Bellomi F; Filippi M
    J Neurol; 2014 Sep; 261(9):1715-25. PubMed ID: 24952616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
    Schlaeger R; Papinutto N; Zhu AH; Lobach IV; Bevan CJ; Bucci M; Castellano A; Gelfand JM; Graves JS; Green AJ; Jordan KM; Keshavan A; Panara V; Stern WA; von Büdingen HC; Waubant E; Goodin DS; Cree BA; Hauser SL; Henry RG
    JAMA Neurol; 2015 Aug; 72(8):897-904. PubMed ID: 26053119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
    Lee H; Nakamura K; Narayanan S; Brown R; Chen J; Atkins HL; Freedman MS; Arnold DL
    Mult Scler; 2018 Jul; 24(8):1055-1066. PubMed ID: 28617152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review.
    Lie IA; Weeda MM; Mattiesing RM; Mol MAE; Pouwels PJW; Barkhof F; Torkildsen Ø; Bø L; Myhr KM; Vrenken H
    Neurology; 2022 Apr; 98(15):e1562-e1573. PubMed ID: 35173016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
    Rocca MA; Preziosa P; Mesaros S; Pagani E; Dackovic J; Stosic-Opincal T; Drulovic J; Filippi M
    Radiology; 2016 Mar; 278(3):841-53. PubMed ID: 26348234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B; Wen J; Cross AH; Yablonskiy DA
    J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased structural white and grey matter network connectivity compensates for functional decline in early multiple sclerosis.
    Fleischer V; Gröger A; Koirala N; Droby A; Muthuraman M; Kolber P; Reuter E; Meuth SG; Zipp F; Groppa S
    Mult Scler; 2017 Mar; 23(3):432-441. PubMed ID: 27246143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
    Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
    Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS.
    Carone DA; Benedict RH; Dwyer MG; Cookfair DL; Srinivasaraghavan B; Tjoa CW; Zivadinov R
    Neuroimage; 2006 Jan; 29(2):505-14. PubMed ID: 16169253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study.
    Magon S; Gaetano L; Chakravarty MM; Lerch JP; Naegelin Y; Stippich C; Kappos L; Radue EW; Sprenger T
    BMC Neurosci; 2014 Sep; 15():106. PubMed ID: 25200127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.